源培生物 (833783.OC)

+ 收藏

现金流量表(源培生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 36,455,621.9578,250,093.2841,413,238.2794,430,299.3753,162,151.22
 收到的税费返还(元) -438,958.95-478,653.00-
 收到其他与经营活动有关的现金(元) 223,224.657,385,658.20292,971.743,004,699.771,182,724.87
 经营活动现金流入小计(元) 36,678,846.6086,074,710.4341,706,210.0197,913,652.1454,344,876.09
 购买商品、接受劳务支付的现金(元) 9,782,790.8418,677,529.567,324,689.3323,454,498.5612,724,354.36
 支付给职工以及为职工支付的现金(元) 9,485,196.4519,601,137.7610,695,905.5918,250,175.7110,391,118.33
 支付的各项税费(元) 3,394,243.9813,454,453.669,854,860.1111,770,970.637,533,143.87
 支付其他与经营活动有关的现金(元) 4,477,343.2714,648,118.564,590,756.008,691,274.213,607,215.63
 经营活动现金流出小计(元) 27,139,574.5466,381,239.5432,466,211.0362,166,919.1134,255,832.19
 经营活动产生的现金流量净额(元) 9,539,272.0619,693,470.899,239,998.9835,746,733.0320,089,043.90
二、投资活动产生的现金流量
 收回投资收到的现金(元) 345,866,691.781,011,576,287.65480,794,849.30641,153,753.43285,492,876.72
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 5,000.0040,707.97---
 投资活动现金流入小计(元) 345,871,691.781,011,616,995.62480,794,849.30641,153,753.43285,492,876.72
 购建固定资产、无形资产和其他长期资产支付的现金(元) 10,670,900.028,960,578.47644,192.274,488,469.17905,441.62
 投资支付的现金(元) 345,000,000.001,010,000,000.00480,000,000.00640,000,000.00285,000,000.00
 投资活动现金流出小计(元) 355,670,900.021,018,960,578.47480,644,192.27644,488,469.17285,905,441.62
 投资活动产生的现金流量净额(元) -9,799,208.24-7,343,582.85150,657.03-3,334,715.74-412,564.90
三、筹资活动产生的现金流量
 分配股利、利润或偿付利息支付的现金(元) 1,253.122,870.06-1,297.721,297.72
 支付其他与筹资活动有关的现金(元) 35,946.8834,329.94-82,702.2882,702.28
 筹资活动现金流出小计(元) 37,200.0037,200.00-84,000.0084,000.00
 筹资活动产生的现金流量净额(元) -37,200.00-37,200.00--84,000.00-84,000.00
四、汇率变动对现金及现金等价物的影响(元) ----390.78-
五、现金及现金等价物净增加额(元) -297,136.1812,312,688.049,390,656.0132,327,626.5119,592,479.00
 加:期初现金及现金等价物余额(元) 100,689,513.0288,376,824.9888,376,824.9856,049,198.4756,049,198.47
 期末现金及现金等价物余额(元) 100,392,376.84100,689,513.0297,767,480.9988,376,824.9875,641,677.47
补充资料:
 净利润(元) 6,832,026.4413,075,142.117,130,640.1334,050,308.6424,675,404.40
 资产减值准备(元) 71,118.6577,740.6711,801.944,481.3325,309.79
 固定资产和投资性房地产折旧(元) 3,760,788.019,046,293.154,528,573.229,040,304.754,525,884.07
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 3,760,788.019,046,293.154,528,573.229,040,304.754,525,884.07
 无形资产摊销(元) 97,775.04195,550.0897,775.04195,550.0897,775.04
 长期待摊费用摊销(元) 366,505.08444,232.53141,604.59202,622.76101,311.38
 处置固定资产、无形资产和其他长期资产的损失(元) 1,422.87-34,285.10---
 固定资产报废损失(元) -6,349.37-34,093.5940.60
 财务费用(元) 1,253.122,870.06-1,688.501,297.72
 投资损失(元) -866,691.78-1,576,287.65-794,849.30-1,153,753.43-492,876.72
 递延所得税(元) -23,247.4127,850.2521,381.15-23,339.82-54,716.26
  其中:递延所得税资产减少(元) -18,420.0722,032.6023,681.00-43,674.44-54,716.26
 递延所得税负债增加(元) -4,827.345,817.65-2,299.8520,334.62-
 存货的减少(元) -1,235,264.73358,883.001,096,949.02-880,544.16-497,421.59
 经营性应收项目的减少(元) 1,672,481.664,358,058.175,059,015.37-10,110,342.75-9,078,162.85
 经营性应付项目的增加(元) -848,570.70-6,631,171.55-7,651,519.773,545,013.92397,255.99
 其他(元) -422,076.96560,724.11-246,467.22370,672.86-33,923.76
 现金的期末余额(元) 100,392,376.84100,689,513.0297,767,480.9988,376,824.9875,641,677.47
 减:现金的期初余额(元) 100,689,513.0288,376,824.9888,376,824.9856,049,198.4756,049,198.47
 现金及现金等价物的净增加额(元) -297,136.1812,312,688.049,390,656.0132,327,626.5119,592,479.00
公告日期 2024-08-282024-04-292023-08-282023-04-262022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院